Patents by Inventor Kelly K. Hunt

Kelly K. Hunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LOW MOLECULAR WEIGHT CYCLIN E (LMW-E) AS A BIOMARKER FOR PERSONALIZATION OF CANCER THERAPIES
    Publication number: 20120114636
    Abstract: Methods are disclosed for predicting a patient response to anti-Her2 therapy or anti-aromatase therapy. In certain embodiments, the methods involve the identification of low molecular weight cyclin E (LMW-E) in cancers, such as breast cancer cells, as a predictive and prognostic marker. In further embodiments, LMW-E expression by a cancerous or pre-cancerous cell may be used to predict response to an aromatase inhibitor and/or CDK2 inhibitor, and determination of LMW-E expression may be used in the personalization of cancer therapies.
    Type: Application
    Filed: March 10, 2010
    Publication date: May 10, 2012
    Applicants: The Board of Regents of the University of Texas System, Research Development Foundation
    Inventors: Khandan Keyomarsi, Nikki Delk, Kelly K. Hunt, Hannah Wingate, Elizabeth A. Mittendorf